MEDIGENE
MDG1.DEMedigene AG (FSE: MDG1, ISIN DE000A1X3W00, Prime Standard) is a publicly listed biotechnology company headquartered in Martinsried near Munich, Germany. With its scientific expertise, Medigene is working on the development of innovative immunotherapies to treat cancer such as T cell receptor-modifie …
© Wikipedia /
Creative Commons CC-BY-SA 3.0 more at Wikipedia
Insider trades and stock quote 2023-2025
Auch interessant? Alle Leerverkauf/Short Positionen bei MEDIGENE
All insider trades at MEDIGENE
Subscribe RSS| Date | Type | Insider | Position | Ø-Price | Volume |
|---|---|---|---|---|---|
| 5/13/2024 | Buy | Zettlmeissl, Dr. Gerd | Director | €1.2 | €12,000 |
| 5/13/2024 | Buy | Ho, Dr. Selwyn | Officer | €1.2 | €32,400 |
| 5/13/2024 | Buy | Mathias, Dr. Frank | Director | €1.2 | €6,964 |
| 5/10/2024 | Buy | Ho, Dr. Selwyn | Officer | €1.2 | €60,000 |
| 5/8/2024 | Buy | Man, Dr. Anthony | Director | €1.6 | €3,875 |
All information without guarantee! No recommendation/consultation!
© Bundesanstalt für Finanzdienstleistungsaufsicht (BaFin)